Top psychiatric drugs in the United States by sales 2016

This statistic displays the some of the best-selling psychiatric drugs in the United States during 2016. During this period, Lyrica generated a revenue of some 4.4 billion U.S. dollars. Lyrica is an anticonvulsant drug marketed by Pfizer. In the United States, it is most commonly used for neuropathic pain.

Selected top psychiatric drugs' U.S. revenue in 2016

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2017

Region

United States

Survey time period

2016

Supplementary notes

This statistic was assembled from several sources.
* Includes sales from Bristol-Myers Squibb and Otsuka (Abilify+Abilify Maintena).

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.